MDR TB, Levofloxacin, Multi-Drug-Resistant Pulmonary Tuberculosis

NCT00495339 · clinicaltrials.gov ↗
PHASE4
Phase
COMPLETED
Status
100
Enrollment
INDUSTRY
Sponsor class

Conditions

Interventions

Sponsor

Sanofi